Gumei Liu

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
O1 The European Social Preferences Measurement (ESPM) study project: social cost value analysis, budget impact, commercial life cycle revenue management, and the economics of biopharmaceutical Research & Development (R&D) The cost of new medicines has never been as controversial as nowadays. Health care policy makers are concerned that rising drug prices(More)
  • 1